Clinical Trial: Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome

U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07635394) titled 'Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome' on May 17.

Brief Summary: To explore the efficacy of pregabalin for patients with irritable bowel syndrome (IBS).

Study Start Date: April 07

Study Type: INTERVENTIONAL

Condition: Irritable Bowel Syndrome (IBS)

Intervention: DRUG: The pregabalin group

75 mg twice daily for 3 days, followed by 150 mg twice daily for 3 days during the first week; 225 mg twice daily at week 10; and a tapering regimen at week 12 (150 mg twice daily for 3 days, then 75 mg twice daily for 3 days).

DRUG: Routine Treatment

Patients also received routine treatment from gastroenterolog...